Professor, Laboratory Medicine and Pathology, Mayo Medical School
Pathology
Dr. Paul J. Kurtin, MD
|
|
Give Review
Paul J. Kurtin, MD works in the field of Pathology. He went to medical school at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54 in research and 62 in primary care medicine He over the years received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Paul J. Kurtin is a published physician. He published 63 publications, including: 'Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.' Dr. Paul J. Kurtin accepts Medicare payments and is registered with Medicare.gov.
Publications
- Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians.
- Personalized risk prediction for event-free survival at 24 months in patients with diffuse large b-cell Lymphoma.
- Correlation of Histomorphologic Pattern of Cardiac Amyloid Deposition with Amyloid Type: A Histologic and Proteomic Analysis of 108 Cases.
- Proteomic Detection of Immunoglobulin Light Chain Variable Region Peptides from Amyloidosis Patient Biopsies.
- Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
- Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
- Clinical Proteome Informatics Workbench Detects Pathogenic Mutations in Hereditary Amyloidoses.
- Mass spectrometry-based proteomics reveals that leukocyte cell-derived chemotaxin 2 associated amyloidosis is a frequent cause of hepatic amyloidosis in the United Sta...
- Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.
- Clonally related follicular Lymphomas and Langerhans cell neoplasms: expanding the spectrum of transdifferentiation.
- Renal amyloidosis associated with a novel sequence variant of gelsolin.
- Endobronchial ultrasound and lymphoproliferative Disorders: a retrospective study.
- Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory Lymphomas.
- Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (ER-CHOP) in patients with previously untreated diffuse large B-cel...
- Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell Lymphoma.
- Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid and Myeloid findings in 87 patients.
- Myelodysplastic syndrome presenting as generalized granulomatous dermatitis.
- Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell Lymphoma.
- Epstein-Barr virus-associated diffuse large B-cell Lymphoma arising on cardiac prostheses.
- HIV lumbosacral radiculoplexus neuropathy mimicking Lymphoma: diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve?
- Indolent Lymphomas of mature B lymphocytes.
- The proposed diagnostic criteria change for chronic lymphocytic Leukemia: unintended consequences?
- Novel immunophenotypic features of marrow lymphoplasmacytic Lymphoma and correlation with Waldenström's macroglobulinemia.
- Spontaneous mutation of hemoglobin Lufkin in a white boy.
- Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell Lymphomas.
- Gene expression profiling of pulmonary mucosa-associated lymphoid tissue Lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications.
- Del(6)(q22) and BCL6 rearrangements in primary CNS Lymphoma are indicators of an aggressive clinical course.
- Low-dose, single-agent temsirolimus for relapsed mantle cell Lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
- Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell Lymphomas using fluorescence in situ hybridization.
- Long-term results of the treatment of patients with mantle cell Lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central C...
- Predictive value of blood and bone marrow flow cytometry in B-cell Lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
- Clinical course and prognosis of smoldering (asymptomatic) multiple Myeloma.
- Treatment of benign orbital pseudoLymphomas with the monoclonal anti-CD20 antibody rituximab.
- Tumor suppressor p16 methylation in multiple Myeloma: biological and clinical implications.
- The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell Lymphoma of mucosa-associated lymphoid tissue (MAL...
- Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's Lymphoma patients.
- Isolated splenic sinus histiocytosis (Rosai-Dorfman Disease) in association with myelodysplastic syndrome.
- Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell Lymphoma from peripheral T-cell lymphom...
- Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
- Lymphoma in rheumatoid arthritis: an immune system set up for failure.
- Adult B-cell Lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
- BLyS and APRIL in rheumatoid arthritis.
- FISH is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular Lymphoma using paraffin-embedded tissue samples.
- Angioimmunoblastic T-cell Lymphoma: a neoplasm of germinal-center T-helper cells?
- Diffuse large B-cell Lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases.
- Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's Lymphoma: a phase II trial in the North Central Cancer Treatment ...
- A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tu...
- Clinical significance of monoclonal B cells in cerebrospinal fluid.
- Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinico...
- An unusual case of leukemic mantle cell Lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
- Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases.
- Primary anaplastic large cell Lymphoma of the central nervous system: prognostic effect of ALK-1 expression.
- Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's Macroglobulinemia is consistently composed of cells along a morphologic continuum of sma...
- Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis.
- Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic Leukemia.
- The continuing increase in the incidence of primary central nervous system non-Hodgkin Lymphoma: a surveillance, epidemiology, and end results analysis.
- Expression of cytolytic lymphocyte-associated antigens in pulmonary Lymphomatoid granulomatosis.
- Mucosa-associated lymphoid tissue Lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue Lymphomas with aneuploidy develop along different pathogenetic...
- A new method to extract nuclei from paraffin-embedded tissue to study Lymphomas using interphase fluorescence in situ hybridization.
- CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis.
- Distinct bone marrow findings in T-cell granular lymphocytic Leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B.
- Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin Lymphoma.
Schools
Medical College of Wisconsin
Vanderbilt University
Brigham Womens Hospital
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Hodgkin's Disease
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
Brigham and Women's Hospital -
Vanderbilt University -
Medical College of Wisconsin
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265404602 |
| Last Name Of The Provider | KURTIN |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Mateusz Opyrchal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph P. Colgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naseema Gangat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vishal S. Chandan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafael Santana-Davila, MD |
|
|
Dr. Shaji K. Kumar, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shernan G. Holtan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Torbenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tow S. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arleigh B. Robertson McCurdy, MD |
|
|
Dr. Robert R. McWilliams, MD |
|
|
Dr. Dong Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie K. Sackett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aleh Bobr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kanaka-Durga S. Vege, MD |